MIT Professor Challenges Transgender Treatment for Minors

An anonymous researcher who participated in a review of Trump-era bomb orders regarding transgender treatments for minors revealed himself as a liberal professor at MIT, Alex Byrne. He emphasized that many reports claiming medical interventions for young children are “empirically or ethically unjustified” may have been exaggerated.

Byrne, a philosophy professor at the prestigious Massachusetts institution and one of nine co-authors of a significant report from the Department of Health and Human Services (HHS), suggested that gender discomfort in young patients should be addressed with psychological treatments rather than transition procedures. Despite identifying himself as someone critical of the current administration and having never voted Republican, he defended the HHS report against fierce backlash from the left. He remarked that it was crafted by a team of experts, not a group driven solely by biases.

The report, prompted by an early executive order from Trump, was said to provide a “cool investigation into what constitutes dramatic medical interventions for healthy minors.” Byrne articulated that after extensive examination of the evidence, along with established medical ethics, the conclusion was clear: transitioning minors medically is not justified either empirically or ethically. He pointed out that these findings align with other health reports from countries like the UK.

Byrne underscored the weaknesses in the so-called “gender-positive” approaches that are currently backed by organizations such as the American Medical Association and the American Academy of Pediatrics. He claimed, for instance, that treatments like puberty blockers and hormone therapies could damage fertility and lead to lifelong sexual dysfunction, aside from other serious risks associated with surgeries like mastectomy.

When the HHS report first emerged, it ignited anger among liberal activists and advocates for transgender rights. Byrne acknowledged that the anonymity of the author likely fueled much of this outrage, with concerns about “personal attacks or professional penalties” due to the contentious nature of the gender health debate. Nevertheless, he maintained that the collective expertise from various fields involved in the review allows for credible and respected documentation.

He stressed that the fierce reactions to the review from medical practitioners highlight the need for rigorous scrutiny of medical treatments for pediatric gender discomfort, similar to any other medical domain. Surprisingly, he noted, such scrutiny often isn’t applied in the U.S.

Byrne concluded by urging people across the political spectrum to engage with the findings, though he expressed uncertainty about whether those early critics would be willing to do so.